Drug recall · January 6, 2021
Dexamethasone - Moxifloxacin PF Injection recall
Why: Lack of assurance of sterility: 13 vials were discovered to have faulty crimps.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Dexamethasone - Moxifloxacin PF Injection (1/5) mg/mL, Imprimis Rx Volume: 1mL/vial, Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B Ledgewood, NJ - 07852 (844)446-6979
- Lots / codes
Lot#: 20JUN010, Exp 5/12/21
- Quantity
- 6520 vials
- Company
- Imprimis NJOF, LLC, Ledgewood, NJ
- Distribution
- U.S.A. Nationwide
- Initiated
- December 17, 2020 · Voluntary: Firm initiated
- Classified
- December 30, 2020
- Reported
- January 6, 2021
- Ended
- August 23, 2023
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Dexamethasone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.